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The Cmr complex carries out target RNA degradation in organisms possessing the CRISPR-Cas system.
In this issue of Structure, Cocozaki et al. present the crystal structure of Cmr2, providing insight into the
architecture of the Cmr complex.The clustered regularly interspaced short
palindromic repeats-CRISPR associated
proteins (CRISPR-Cas) systems are
recently discovered self-defense systems
against invading genetic elements found
in bacteria and archaea (Barrangou
et al., 2007; Brouns et al., 2008). In a
CRISPR-Cas system, the CRISPR locus
is transcribed into a long primary tran-
script, which is then processed into
a library of short CRISPR-derived RNAs
(crRNAs). Each crRNA is loaded into
a multiple protein complex (Cas complex)
that carries out degradation of nucleic
acids. From studies reported so far, the
majority of the targets for degradation
are DNAs (Garneau et al., 2010). However,
a subset of the Cas complex, the Cas
module RAMP (Cmr) complex, was
shown to cleave target RNA in vitro and
in vivo (Hale et al., 2012; Hale et al.,
2009). From a structural point of view,
significant progress has recently been
made in understanding how the Cas
complex recognizes DNA for degradation,
exemplified by a recent EM structure of
Cascade (Wiedenheft et al., 2011). On
the other hand, little is known about target
RNA recognition and degradation by the
Cmr complex. In this issue of Structure,
Cocozaki et al. (2012) presents the crystal
structure of Cmr2 from Pyrococcus
furiosus (Pf). The structure, combined
with functional analyses, reveals a few
surprises, sheds some light on the archi-
tecture of the Cmr complex, and raises a
few questions regarding the mechanism
of target RNA recognition and cleavage
by the Cmr complex.
The Cmr complex from Pf (Pf Cmr) is
composed of six proteins, Cmr1–6. Four
of the six subunits are RNA-binding
proteins of the repeat-associated myste-
rious proteins (RAMP) family. Pf Cmr2,
which is not a RAMP protein, is the largest
subunit in the complex (100 kDa, and therest of the subunits range from 20 to
39 kDa). Cmr2 was predicted to have a
nuclease domain of the histidine, aspartic
acid (HD) family, a zinc ribbon domain,
and a DNA polymerase-like domain (Ma-
karova et al., 2002). Because of its size
and, more importantly, the presence of
the nuclease domain, Cmr2 was thought
to be the catalytic subunit of the Cmr
complex. However, the findings from Co-
cozaki et al. (2012) now tell a different story.
The first unexpected finding was from
a functional assay using the Pf Cmr
complex assembled from a truncated
Pf Cmr2 that lacks the N-terminal HD
nuclease domain (Pf Cmr2dHD). The
complex with the truncated Pf Cmr2
cleaved target RNA as effectively as the
one with the full-length protein in vitro,
demonstrating that the element respon-
sible for target RNA cleavage does not
reside in the HD nuclease domain.
Having demonstrated that the
N-terminal nuclease domain of Pf Cmr2
is not required for target RNA cleavage,
Cocozaki et al. (2012) solved the crystal
structure of Pf Cmr2dHD, which provides
additional surprises. Instead of a poly-
merase-like fold, the structure of Pf
Cmr2dHD shows a fold of two ferre-
doxin-like domains and two small helical
domains. Furthermore, two CXXC motifs
form two disulfide bonds instead of the
predicted zinc ribbon domain. Structural
search and comparison with known
protein structures showed that the two
ferredoxin-like domains resemble the ad-
enylyl cyclase homodimer, implying that
Pf Cmr2 might have adenylyl cyclase-
like activity. Soaking crystals of Pf
Cmr2dHD with ADP and divalent ions
prior to data collection indeed produced
a structure of Pf Cmr2dHD with ADP and
metal ions bound. However, functional
assays of Pf Cmr2dHD, either alone or in
the Pf Cmr complex, failed to detectStructure 20, March 7, 2012any enzymatic activity of Cmr2dHD to
hydrolyze ATP. In addition, mutations of
the conserved residues responsible for
ADP and metal ion binding did not affect
target RNA cleavage by the Pf Cmr com-
plex assembled with the Pf Cmr2dHD
mutants.
The structure of Pf Cmr2dHD by Co-
cozaki et al. (2012) provides insight into
the architecture of the Cmr complex.
Additional functional analyses indicate
that Cmr2 is unlikely to be the catalytic
subunit of the Cmr complex for target
RNA cleavage. Thus, the studies raise
two intriguing questions: (1) if Cmr2 is
not responsible for target RNA cleavage,
what is its role in the Cmr complex?, and
(2) if Cmr2 is not the catalytic subunit,
which subunit in the Cmr complex is
responsible for target RNA cleavage?
Because Cmr2 is the largest subunit in
the Cmr complex, it is reasonable to
hypothesize that it serves as the structural
foundation of the complex where other
Cmr proteins interact. Such a role does
not require enzymatic activity, consistent
with the results from ATP hydrolysis and
mutagenesis (Cocozaki et al., 2012).
Studies of pair-wise protein-protein inter-
actions of the six proteins constituting
the Pf Cmr complex should shed some
light on the validity of the hypothesis.
Recently, Zhang et al. (2012) reported
low resolution EM structures of the Cmr
complex from Sulfolobus solfataricus.
Sequence alignments indicate that the
subunits of the Pf Cmr complex are
homologous to their counterparts in the
SsoCmr complex, although the degree
of the sequence identities varies among
different subunits. Therefore, docking
the high-resolution crystal structure of
Pf Cmr2dHD into the low-resolution EM
structure of the SsoCmr complex may
also shed light on the possible function
of Cmr2.ª2012 Elsevier Ltd All rights reserved 389
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PreviewsDue to the lack of effect of mutations on
target RNA cleavage, Cocozaki et al.
(2012) suggested that the ribonuclease
activity might reside in other Pf Cmr
proteins. This is entirely reasonable, as
some RAMP proteins have been shown
to possess nuclease activity. Cmr5 can
immediately be ruled out, because the
Pf Cmr complex lacking Pf Cmr5 was
able to cleave target RNA (Hale et al.,
2009). Among the remaining subunits
(Cmr1, Cmr3, Cmr4, and Cmr6), Cmr3
appears to be the best candidate as the
nuclease, because the EM structure
showed that SsoCmr3 is located near
the center of the SsoCmr complex, where
the RNA cleavage is expected to occur
(Zhang et al., 2012). However, the re-
ported difference of the cleaved RNA
products by the Cmr complexes from
these two organisms complicates the
hunt for the nuclease, but it also makes
mechanistic study more interesting. While
the target RNA cleaved by Pf Cmr com-
plex produced 20,30-cyclic phosphate390 Structure 20, March 7, 2012 ª2012 Elsevand 50-OH (Hale et al., 2009), the cleavage
products of the SsoCmr complex con-
tained 30-OH and 50-phosphate (Zhang
et al., 2012). It is difficult to envision a
highly homologous subunit of the Cmr
complex cleaving target RNA with two
distinct mechanisms. Therefore, if the
analyses of the ends of the cleaved RNA
stand, the best candidate for the nuclease
would be Cmr1, as it is the least con-
served, both in amino acid sequence and
size, among all subunits of the Cmr
complex. Regardless of the final outcome,
the hunt for the nuclease responsible for
target RNA cleavage is shaping up to be
an interesting one, and there are bound
to be more surprises along the way.REFERENCES
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